BITS Pilani Institutional Repository: Search

Search

Results 41-50 of 773 (Search time: 0.003 seconds).

previous
1
...
2
3
4
5
6
7
8
...
78
next

Item hits:

Issue Date	Title	Author(s)
2017-08	Ondansetron ameliorates depression associated with obesity in high-fat diet fed experimental mice: An investigation-based on the behavioral, biochemical, and molecular approach	Mahesh, R.
2014-04	Role of Serotonin Type-1A/B (Hydroxytryptamine) Receptors in Depression Revisited	Mahesh, R.
2015-05	Type 4 phosphodiesterase enzyme inhibitor, rolipram rescues behavioral deficits in olfactory bulbectomy models of depression: Involvement of hypothalamic–pituitary–adrenal axis, cAMP signaling aspects and antioxidant defense system	Mahesh, R.
2015	Insignificant in vitro falcipain-2 inhibitory activity of novel 2-(4-(substituted benzoyl) piperazine-1-yl)-N-phenylacetamide derivatives	Mahesh, R.
2010	Demographic study on disease prevalence and their treatment pattern in a local hospital of a semi-urban community	Mahesh, R.
2013	Anxiolytic Effect of a Novel 5-HT3 Receptor Antagonist (4-Phenylpiperazin-1-yl)(Quinoxalin-2-yl) Methanone (4a) in a Battery of Behavioral Models for Anxiety in Mice	Mahesh, R.
2015-01	Piperazine Analogs of Naphthyridine-3-carboxamides and Indole-2-carboxamides: Novel 5-HT3 Receptor Antagonists with Antidepressant-Like Activity	Mahesh, R.
2010-02	Review: The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target?	Mahesh, R.
2016-01	4i (N-(3-Chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist alleviates depressive behavior evoked in streptozotocin-induced diabetic mice: Role of oxidative stress	Mahesh, R.
2013	Neuro-pharmacological evaluation of structurally novel 5-hydroxytryptamine type 3 receptor antagonist, N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n) for its anxiolytic potential	Mahesh, R.